Table 4.

Multivariable Analysis of Outcomes (Hazard Ratio [95% confidence limits, p-value))

	Relapse	NRM	Mortality or Relapse	Overall Mortality
Patient/Donor Sex
M/M	1
F/F	4.64 (1.20–18.01, p=.03)
F/M	1.86 (0.45–7.69, p=.39)
M/F	1.60 (0.35–7.19, p=.54)
	Global p=.10
MDAPS	1.65 (1.11–2.45, p=.01)
Hematocrit		0.92 (0.84–1.00, p=.06)		0.94 (0.88–1.00, p=.04)
HCT-CI
0–2	1	1	1	1
>2		3.97 (1.54–10.23, p=.004)	2.46 (1.33–4.54, p=.004)	2.62 (1.36–5.05, p=.004)
Cytogenetics (IPSS)
Good/Interm.	1	1	1	1
Poor		3.09 (1.21–7.88, p=.02)	3.35 (1.73–6.48, p=.0003)	2.73 (1.37–5.44, p=.004)
Age		1.04 (1.00–1.07, p=.06)	1.03 (1.01–1.06, p=.009)	1.03 (1.00–1.05, p=.02)

Abbreviations: CI = confidence interval; F = female; HCT-CI = Hematopoietic cell transplantation co-morbidity index; HR = hazard ratio; IPSS = International Prognostic Scoring System; M = male; NRM = Non-relapse mortality. MDAPS = MD Anderson Prognostic Score.